| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | Director | $11.6K | Sep 3, 2025 | ||
| FSTX | F-star Therapeutics, Inc. | PRESIDENT AND CEO, Director | Mar 8, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|